This federal contract award, valued at $9,383.68, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of Imitrex 6 mg/0.5 ml pen injections. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $18,290.54, is for the delivery of Imitrex 6 mg/0.5 ml pen injectors to support medical programs and services. This is a delivery order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a comprehensive range...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a large pharmaceutical distributor, for the supply of Imitrex 6 mg/0.5 ml pen injectors. The fixed-price delivery order, valued at $12,343.56, has an ultimate completion date of September 20, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999 through December 2025, to deliver a wide range of medical...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,439.13 firm fixed-price delivery order is for the supply of Imitrex 6 mg/0.5 ml pen injectors, with an ultimate completion date of August 2, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Imitrex 6 mg/0.5 ml pen injectors. The contract is a delivery order valued at $5,817.24, with a firm fixed price pricing type and an ultimate completion date of August 8, 2024. The contract is not set aside for any specific business category. Amerisourcebergen, through its Corporate Office division, has been awarded numerous...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of IMITREX 6 MG/0.5 ML PEN INJECT 0.5ML, a medication used to treat migraine headaches. The contract has a ceiling value of $1,912.02 and is a firm fixed-price delivery order that will run through October 16, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $8,494.69, is a delivery order for Imitrex 6 mg/0.5 ml pen injectors. The contract is a firm fixed-price agreement with an ultimate completion date of July 24, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,510.23, is a Firm Fixed Price Delivery Order for the provision of IMITREX 6 MG/0.5 ML PEN INJECT 0.5ML, a medication used to treat migraines. The contract has an ultimate completion date of May 8, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of IMITREX 6 MG/0.5 ML PEN INJECT 0.5ML. The contract, valued at $1,399.20, is a firm fixed-price delivery order with a completion date of July 28, 2023. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen, the prime contractor, holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award, with ID SPE2DB24D3013|SPE2DB25FFGRN, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Imitrex 4 mg/0.5 ml pen injectors, a prescription medication used to treat migraines. The contract has a firm fixed price of $2,007.08 and an ultimate completion date of November 21, 2024. This award is not designated as a set-aside contract....